Skip to Main Content

Paper Details

The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.
Diabetes Obes Metab
6
2021
Author NameAffiliation
Christopher P CannonBrigham & Women's Hospital and Baim Institute for Clinical Research
Tara I ChangStanford University
Tara I ChangStanford Center for Clinical Research, Stanford University School of Medicine
Bernard ZinmanLunenfeld-Tanenbaum Research Institute, Mt Sinai Hospital, University of Toronto
Kenneth W Mahaffey
  • 1 - 5

Datasets

Release 1.2